Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kreisl TN"'
Publikováno v:
Journal of Brain Tumors & Neurooncology.
Background: Tumor-induced Central Neurogenic Hyperventilation (CNH) is exceedingly rare, about half resulting from Primary CNS Lymphoma (PCNSL) despite their rarity. Results: We present a 75 year-old, immunocompetent woman with recurrent PCNSL leadin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fed3eb6861e2c6f0c434a2db4c0816f
https://doi.org/10.4172/2475-3203.1000107
https://doi.org/10.4172/2475-3203.1000107
Autor:
Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA, Kreisl, Teri N, Kim, Lyndon, Moore, Kraig, Duic, Paul, Royce, Cheryl, Stroud, Irene, Garren, Nancy
Publikováno v:
Journal of Clinical Oncology; 2/10/2009, Vol. 27 Issue 5, p740-745, 6p
Autor:
Morris MJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: morrism@mskcc.org., Castellano D; Medical Oncology Department, Hospital Universitario 12 de Octubre, I+12 Research Institute, Madrid, Spain., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, German Cancer Consortium-University Hospital Essen, Essen, Germany; National Center for Tumor Diseases, NCT West, Heidelberg, Germany., de Bono JS; The Institute of Cancer Research and The Royal Marsden Hospital, London, UK., Shore ND; Carolina Urologic Research Center, AU Clinics, Myrtle Beach, SC, USA., Chi KN; BC Cancer, Vancouver, BC, Canada., Crosby M; Veterans Prostate Cancer Awareness, San Diego, CA, USA., Piulats JM; Catalan Institute of Oncology, Barcelona, Spain., Fléchon A; Centre Léon-Bérard, Lyon, France., Wei XX; Dana-Farber Cancer Institute, Boston, MA, USA., Mahammedi H; Centre Jean Perrin, Clermont-Ferrand, France., Roubaud G; Institut Bergonié, Bordeaux, France., Študentová H; Department of Oncology, Palacký University, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic., Nagarajah J; Radboud University Medical Centre, Nijmegen, Netherlands; Roentgeninstitut Düsseldorf, Düsseldorf, Germany., Mellado B; Medical Oncology Department, Hospital Clínic de Barcelona, Institut d' Investigacions Biomèdiques Pi i Sunyer, University of Barcelona, Barcelona, Spain., Montesa-Pino Á; UGCI Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, IBIMA, Málaga, Spain., Kpamegan E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Ghebremariam S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Kreisl TN; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Wilke C; Novartis Pharma AG, Basel, Switzerland., Lehnhoff K; Novartis Pharma AG, Basel, Switzerland., Sartor O; Mayo Clinic, Rochester, MN, USA., Fizazi K; Gustave Roussy Institute, Paris-Saclay University, Paris, France.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Sep 28; Vol. 404 (10459), pp. 1227-1239. Date of Electronic Publication: 2024 Sep 15.
Autor:
Barbaro M; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Blinderman CD; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Iwamoto FM; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Kreisl TN; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Welch MR; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Odia Y; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Donovan LE; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Joanta-Gomez AE; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Evans KA; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY., Lassman AB; From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY. abl7@cumc.columbia.edu.
Publikováno v:
Neurology [Neurology] 2022 Jan 18; Vol. 98 (3), pp. e260-e266. Date of Electronic Publication: 2021 Nov 18.
Autor:
Odia Y; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, 9th Floor, NI 9-017, New York, NY, 10032, USA. yo2240@cumc.columbia.edu., Iwamoto FM; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, 9th Floor, NI 9-017, New York, NY, 10032, USA., Moustakas A; University of Vermont Medical Center, 89 South Williams Street, Burlington, VT, 05401, USA., Fraum TJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, Campus Box 8131, 510 S. Kingshighway Blvd., Saint Louis, MO, 63110, USA., Salgado CA; University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD, 21201, USA., Li A; Center for Cancer Research, National Cancer Institute, Building 37, Room 1142, Bethesda, MD, 20892, USA., Kreisl TN; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, 9th Floor, NI 9-017, New York, NY, 10032, USA., Sul J; Federal Drug Administration, 10903 New Hampshire Ave, Bldg WO22 Rm 2331, Silver Spring, MD, 20993, USA., Butman JA; Department of Radiology, National Institutes of Health Clinical Center, Building 10, Clinical Center 10 Center Drive, MSC 1074, Bethesda, MD, 20892, USA., Fine HA; Division of Neuro-Oncology, Director of the Brain Tumor Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, 1305 York Avenue, 9th Floor, New York, NY, 10021, USA.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2016 Mar; Vol. 127 (1), pp. 127-35. Date of Electronic Publication: 2015 Dec 07.
Autor:
Odia Y; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians & Surgeons, 710 West 168th Street, 9th Floor, New York, NY 10032, USA., Sul J; US FDA, 10903 New Hampshire Ave, Bldg WO22 Rm 2331, Silver Spring, MD 20993, USA., Shih JH; Biometric Research Branch, Division of Cancer Treatment & Diagnosis, NCI, 9609 Medical Center Drive, Room 5W124, Rockville, MD 20850, USA., Kreisl TN; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians & Surgeons, 710 West 168th Street, 9th Floor, New York, NY 10032, USA., Butman JA; Department of Radiology, National Institutes of Health Clinical Center, Building 10, Clinical Center 10 Center Drive, MSC 1074, Bethesda, MD 20892, USA., Iwamoto FM; Neuro-Oncology Division, Neurological Institute of New York, Columbia University College of Physicians & Surgeons, 710 West 168th Street, 9th Floor, New York, NY 10032, USA., Fine HA; Division of Neuro-Oncology, Director of the Brain Tumor Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, 1305 York Avenue, 9th Floor, New York, NY 10021, USA.
Publikováno v:
CNS oncology [CNS Oncol] 2016; Vol. 5 (2), pp. 59-67. Date of Electronic Publication: 2016 Feb 10.
Autor:
Odia Y; Division of Neuro-Oncology, Neurological Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, NI 9-017, New York, NY, 10032, USA. yo2240@cumc.columbia.edu., Kreisl TN; Division of Neuro-Oncology, Neurological Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, NI 9-017, New York, NY, 10032, USA., Aregawi D; Division of Neuro-oncology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA., Innis EK; University of Maryland School of Medicine, Baltimore, MD, USA., Fine HA; Division of Neuro-Oncology, Director of the Brain Tumor Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2015 Oct; Vol. 125 (1), pp. 191-5. Date of Electronic Publication: 2015 Aug 19.
Autor:
Odia Y; Division of Neuro-Oncology, Neurologic Institute of New York, Columbia University College of Physicians and Surgeons, 710 West 168th Street, NI 9-017, New York, NY, 10032, USA, yo2240@cumc.columbia.edu., Shih JH, Kreisl TN, Fine HA
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2014 Nov; Vol. 120 (2), pp. 431-40. Date of Electronic Publication: 2014 Aug 07.
Autor:
Peer CJ; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, United States., Brown JL, Martin TJ, Roth J, Spencer SD, Brassil P, McNeill KA, Kreisl TN, Fine HA, Figg WD
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2013 Dec 30; Vol. 942-943, pp. 107-12. Date of Electronic Publication: 2013 Oct 22.
Autor:
Kreisl TN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Road, #225, Bethesda, MD 20892, USA. kreislt@mail.nih.gov, Smith P, Sul J, Salgado C, Iwamoto FM, Shih JH, Fine HA
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2013 Jan; Vol. 111 (1), pp. 41-8. Date of Electronic Publication: 2012 Oct 20.